MS-DRG 830Surgical

Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures without CC/MCC

Major Diagnostic Category 17·Grouped by procedure·FY 2027

MS-DRG 830 is a Surgical Medicare Severity Diagnosis Related Group under Major Diagnostic Category 17 (MDC 17) without a significant Complication or Comorbidity. It maps to 110 ICD-10-CM diagnosis codes. For FY 2027 it carries a relative weight of 1.4859 with a geometric mean length of stay of 2 days and an arithmetic mean of 2.4 days. Hospitals use this grouping to determine reimbursement for inpatient stays under Medicare.

Advertisements

FY 2027 payment data

From Table 5 of the FY 2027 IPPS Final Rule (CMS).

Relative weight:
1.4859 (payment multiplier vs. the average case (1.0))
Geometric mean stay:
2 days (used for transfer payments)
Average stay:
2.4 days (arithmetic mean)
Post-acute transfer policy:
No (not subject to it)

Same condition, other severity levels

CMS splits one condition into separate DRGs by how sick the patient is. With MCC pays more than with CC, which pays more than without CC/MCC.

DRGTitleRelative weightMean stay
829Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures with CC/MCC3.12815.6 days
830Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures without CC/MCC (this page)1.48592 days

Procedure codes (189)

ICD-10-PCS procedures that can group a stay to DRG 830.

Diagnosis codes (110)

As the principal diagnosis, these ICD-10-CM codes can group to DRG 830. 100% of the codes listed are billable.